Public consultation on interim decisions to amend the Poisons Standard - ACMS & Joint ACMS-ACCS JUNE, 2025

Overview

Interim decisions regarding substances discussed at the expert advisory meetings. 

This consultation is for interim decisions made in relation to substances that were discussed at the JUNE 2025 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the ACMS and the Advisory Committee on Chemicals Scheduling (ACCS) in joint session.

Kindly note that the interim decisions published below may differ from the initial proposal. Please read through the proposed interim decisions which can be accessed through the links below and are available on the consultation page for your convenience.

Once you are familiar with the interim decision, please provide your comments and votes in relation to the interim decision.

The closing date for this consultation is close of business 10 July 2026. All submissions received by the deadline will be considered by the delegate before they make a final decision.

The interim decisions under consultation are detailed in the Public notice of interim decisions JUNE 2025 which can be accessed below: 

• Public Notice of interim decisions, June 2025

Substances for which public comment is sought:

ACMS

• SOMATROGON, LONAPEGSOMATROPIN and SOMAPACITAN
• 6-METHYLNICOTINE

Note: Public consultation on the interim decision on psilocybine which was also referred to the ACMS meeting in June 2025, is being conducted separately.

JOINT ACMS-ACCS

• AZELAIC ACID
• EXTRACTS AND ESSENTIAL OILS PRIMARILY COMPOSED OF METHYL SALICYLATE

What happens next

All public submissions will be published on the TGA website at Public submissions on scheduling matters, unless marked confidential or indicated otherwise in the submission information (see Privacy and your Personal information).

Public submissions are an important part of the process for amending the Poison Standard, and are published on the TGA website using the consultation hub.  Submissions by the public may not reflect the views of the Department of Health, Disability, and Ageing or TGA.  Published submissions should not be taken as being endorsed by the Department or TGA.

Following consideration of public submissions received before the closing date and advice from the expert advisory committees, decisions on the proposed amendments are anticipated to be published as final decisions on the TGA website: Scheduling delegate's final decisions at a later date.